Expression of MAPK and PI3K/AKT/mTOR Proteins according to the Chronic Liver Disease Etiology in Hepatocellular Carcinoma

Figure 2

Frequency of strong expression of PI3K/AKT/mTOR pathway proteins in hepatocellular carcinoma patients according to the etiology of underlying chronic liver disease in tumor and adjacent cirrhosis.